A clinical trial involving insulin lispro was updated on September 28, 2026. The study, titled "Effects of Antipsychotics on Brain Insulin Action in Females," is registered under identifier NCT06251635. Its current status is listed as active, not recruiting. The trial phase is listed as not applicable. No results have been posted as part of this update. The trial record does not specify findings, outcomes, or conclusions at this time. This update reflects only the trial's status as of the listed date, not any outcome data. Readers should note that status changes in clinical trials do not indicate efficacy or safety conclusions. Further updates may be issued as the trial progresses toward completion or results posting. For additional context on insulin lispro, including its approved uses and regulatory status, readers can consult the compound overview.
Insulin Lispro Trial Update: "Antipsychotics and Brain Insulin Action" Active
See the full insulin lispro overview
Source: https://clinicaltrials.gov/study/NCT06251635